Nephrogenic diabetes insipidus

Common Name(s)

Nephrogenic diabetes insipidus, Nephrogenic diabetes insipidus, x-linked

Nephrogenic diabetes insipidus is a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine. Nephrogenic diabetes insipidus occurs when the kidney tubules, which allow water to be removed from the body or reabsorbed, do not respond to a chemical in the body called antidiuretic hormone (ADH) or vasopressin. ADH normally tells the kidneys to make the urine more concentrated. As a result of the defect, the kidneys release an excessive amount of water into the urine, producing a large quantity of very dilute urine.

Nephrogenic diabetes insipidus can be either acquired or hereditary. The acquired form is brought on by certain drugs and chronic diseases and can occur at any time during life. The hereditary form is caused by genetic mutations, and its signs and symptoms usually become apparent within the first few months of life.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Nephrogenic diabetes insipidus" for support, advocacy or research.

Logo
Nephrogenic Diabetes Insipidus Network

The NDI Foundation was formed to support education, research, treatment and cure for Nephrogenic Diabetes Insipidus. Our goal is to create a communication channel to serve the entire NDI community: patients and their families, researchers, physicians and other health care providers. The NDI foundation has helped to stimulate clinical trials and ongoing research to improve the therapy and treatment options for this kidney disorder. While we focus on research, we enthusisaticly provide information to help educate patients and famalies on treatment options, support groups and the lastest research news.

Last Updated: 9 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Nephrogenic diabetes insipidus" for support, advocacy or research.

Logo
Nephrogenic Diabetes Insipidus Network

The NDI Foundation was formed to support education, research, treatment and cure for Nephrogenic Diabetes Insipidus. Our goal is to create a communication channel to serve the entire NDI community: patients and their families, researchers, physicians and other health care providers. The NDI foundation has helped to stimulate clinical trials and ongoing research to improve the therapy and treatment options for this kidney disorder. While we focus on research, we enthusisaticly provide information to help educate patients and famalies on treatment options, support groups and the lastest research news.

http://www.ndif.org

Last Updated: 9 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Nephrogenic diabetes insipidus" returned 122 free, full-text research articles on human participants. First 3 results:

Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.
 

Author(s): Craig E Gordon, Swapna Vantzelfde, Jean M Francis

Journal: N. Engl. J. Med.. 2016 11;375(20):2008-2009.

 

Last Updated: 13 Dec 2016

Go To URL
Congenital Nephrogenic Diabetes Insipidus Presented With Bilateral Hydronephrosis and Urinary Infection: A Case Report.
 

Author(s): Kewen Zheng, Yi Xie, Hanzhong Li

Journal: Medicine (Baltimore). 2016 May;95(22):e3464.

 

Nephrogenic diabetes insipidus (NDI) is a condition resulting from the kidney's impaired response to circulating antidiuretic hormone (ADH), leading to polydipsia and polyuria. Urinary tract dilatation caused by NDI is a rare situation. Here, we report a case of congenital NDI presented ...

Last Updated: 4 Jun 2016

Go To URL
A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
 

Author(s): Gitte R Hinrichs, Louise H Hansen, Maria R Nielsen, Christina Fagerberg, Hans Dieperink, Søren Rittig, Boye L Jensen

Journal: Physiol Rep. 2016 Apr;4(8):.

 

Mutations in the vasopressin V2 receptor gene AVPR2 may cause X-linked nephrogenic diabetes insipidus by defective apical insertion of aquaporin-2 in the renal collecting duct principal cell. Substitution mutations with exchange of arginine at codon 137 can cause nephrogenic syndrome ...

Last Updated: 27 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Nephrogenic diabetes insipidus" returned 12 free, full-text review articles on human participants. First 3 results:

Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.
 

Author(s): B K Kishore, N G Carlson, C M Ecelbarger, D E Kohan, C E Müller, R D Nelson, J Peti-Peterdi, Y Zhang

Journal: Acta Physiol (Oxf). 2015 Jun;214(2):176-88.

 

Lithium still retains its critical position in the treatment of bipolar disorder by virtue of its ability to prevent suicidal tendencies. However, chronic use of lithium is often limited by the development of nephrogenic diabetes insipidus (NDI), a debilitating condition. Lithium-induced ...

Last Updated: 12 May 2015

Go To URL
Congenital nephrogenic diabetes insipidus with end-stage renal disease.
 

Author(s): Hyun Ho Ryu, Jong Hoon Chung, Byung Chul Shin, Hyun Lee Kim

Journal: Korean J. Intern. Med.. 2015 Mar;30(2):259-61.

 

Last Updated: 9 Mar 2015

Go To URL
A novel therapeutic effect of statins on nephrogenic diabetes insipidus.
 

Author(s): Leonilde Bonfrate, Giuseppe Procino, David Q-H Wang, Maria Svelto, Piero Portincasa

Journal: J. Cell. Mol. Med.. 2015 Feb;19(2):265-82.

 

Statins competitively inhibit hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase, resulting in reduced plasma total and low-density lipoprotein cholesterol levels. Recently, it has been shown that statins exert additional 'pleiotropic' effects by increasing expression levels ...

Last Updated: 29 Jan 2015

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
 

Status: Not yet recruiting

Condition Summary: Lithium Use, Nephrogenic Diabetes Insipidus

 

Last Updated: 1 Jun 2017

Go to URL
Metformin and Congenital Nephrogenic Diabetes Insipidus
 

Status: Recruiting

Condition Summary: Diabetes Insipidus

 

Last Updated: 31 Oct 2016

Go to URL